142 related articles for article (PubMed ID: 26022840)
1. Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Penthala NR; Thakkar S; Crooks PA
Bioorg Med Chem Lett; 2015 Jul; 25(14):2763-7. PubMed ID: 26022840
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
5. Dioxol and dihydrodioxin analogs of 2- and 3-phenylacetonitriles as potent anti-cancer agents with nanomolar activity against a variety of human cancer cells.
Madadi NR; Ketkar A; Penthala NR; Bostian AC; Eoff RL; Crooks PA
Bioorg Med Chem Lett; 2016 May; 26(9):2164-9. PubMed ID: 27017113
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
Du C; Dong MH; Ren YJ; Jin L; Xu C
J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
[TBL] [Abstract][Full Text] [Related]
8. 3-substituted 2-phenylimidazo[2,1-b]benzothiazoles: synthesis, anticancer activity, and inhibition of tubulin polymerization.
Kamal A; Sultana F; Ramaiah MJ; Srikanth YV; Viswanath A; Kishor C; Sharma P; Pushpavalli SN; Addlagatta A; Pal-Bhadra M
ChemMedChem; 2012 Feb; 7(2):292-300. PubMed ID: 22241597
[TBL] [Abstract][Full Text] [Related]
9. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins.
Jiménez C; Ellahioui Y; Álvarez R; Aramburu L; Riesco A; González M; Vicente A; Dahdouh A; Ibn Mansour A; Jiménez C; Martín D; Sarmiento RG; Medarde M; Caballero E; Peláez R
Eur J Med Chem; 2015 Jul; 100():210-22. PubMed ID: 26092446
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Hashemi SM; Mirzaei H; Fallah M; Emami S
Bioorg Chem; 2019 Dec; 93():103300. PubMed ID: 31586708
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.
Mazué F; Colin D; Gobbo J; Wegner M; Rescifina A; Spatafora C; Fasseur D; Delmas D; Meunier P; Tringali C; Latruffe N
Eur J Med Chem; 2010 Jul; 45(7):2972-80. PubMed ID: 20395019
[TBL] [Abstract][Full Text] [Related]
13. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
14. A novel tetrazole analogue of resveratrol is a potent anticancer agent.
Bommagani S; Penthala NR; Balasubramaniam M; Kuravi S; Caldas-Lopes E; Guzman ML; Balusu R; Crooks PA
Bioorg Med Chem Lett; 2019 Jan; 29(2):172-178. PubMed ID: 30528695
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of aminostilbene-arylpropenones as tubulin polymerization inhibitors.
Kamal A; Kumar GB; Polepalli S; Shaik AB; Reddy VS; Reddy MK; Reddy ChR; Mahesh R; Kapure JS; Jain N
ChemMedChem; 2014 Nov; 9(11):2565-79. PubMed ID: 25146959
[TBL] [Abstract][Full Text] [Related]
18. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4.
Nguyen TT; Lomberget T; Tran NC; Colomb E; Nachtergaele L; Thoret S; Dubois J; Guillaume J; Abdayem R; Haftek M; Barret R
Bioorg Med Chem Lett; 2012 Dec; 22(23):7227-31. PubMed ID: 23063401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
